arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

PRF Technologies Ltd.

PRFX
$0.77 ▲ +0.02 (+3.14%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
9 Visible periods
22 Metrics
Peer-ranked Benchmarks
Price Chart
26
Health
Poor
Bearish
auto_awesome

Analytical Summary

PRF Technologies Ltd. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -60.1% ↗
FCF / Share $-6.11 ↗
Trailing P/E —
Price / Book 0.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$17.00K
— —
Net Income Profit after all expenses
$-5.02M
↑ +65.6% —
FCF / Share Free cash flow per share
$-6.11
↑ +93.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
15
Cash Quality ↓
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 9 years · 9 quarters